Skip to content
OpenCapital
Get started

Edwards Lifesciences EW United States — Net Sales

Other segment segments

Europe
$442.6M+29.5%
Rest of World
$177.8M+18.4%
Japan
$90.6M+10.8%

Similar metrics at other companies

Enovis logo
ENOVUnited States — Net Sales
$323.83M+4.0%
Avanos Medical logo
AVNSUnited States — Net Sales
$130.8M-1.1%
CONMED logo
CNMDUnited States — Net Sales
$173.06M-5.8%
AngioDynamics logo
ANGOUnited States — Net Sales
$67.28M+9.7%
Globus Medical logo
GMEDUnited States — Net Sales
$604.89M+25.0%
Medtronic logo
MDTUnited States — Net Sales
$4.87B+7.1%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Operating income$477.6M+21.0%
Net income$380.7M+6.3%
EPS (diluted)$0.66+8.2%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.66B+19.3%
Enterprise value$49.92B+22.2%
P/E47.1×+36.8×
P/S8.2×+0.4×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%—

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's united states — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's united states — net sales?
Edwards Lifesciences (EW) reported united states — net sales of $937.6M in Q1 2026.
How has Edwards Lifesciences's united states — net sales changed year-over-year?
Edwards Lifesciences's united states — net sales increased by 11.8% year-over-year, from $838.9M to $937.6M.
What is the long-term trend for Edwards Lifesciences's united states — net sales?
Over 4 years (2021 to 2025), Edwards Lifesciences's united states — net sales has grown at a 4.6% compound annual growth rate (CAGR), from $2.96B to $3.54B.
What does united states — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and structural heart technologies within the United States market. It serves as a primary indicator of the company's domestic market penetration and the demand for its core product portfolio. Tracking this figure helps investors assess the company's ability to maintain its competitive position in its largest geographic market.